AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.220
+0.250 (6.30%)
Jun 29, 2026, 3:17 PM EDT - Market open
AVITA Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 7.17, with a low estimate of 5.50 and a high estimate of 10. The average target predicts an increase of 69.91% from the current stock price of 4.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $6 | Buy | Reiterates | $6 | +42.18% | Jun 26, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 23, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $5.5 | Buy | Reiterates | $5.5 | +30.33% | Jun 18, 2026 |
| Northland Securities | Northland Securities | Buy Maintains $10 | Buy | Maintains | $10 | +136.97% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
82.37M
from 71.61M
Increased by 15.03%
Revenue Next Year
105.42M
from 82.37M
Increased by 27.98%
EPS This Year
-1.11
from -1.74
EPS Next Year
-0.82
from -1.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 84.3M | 133.4M | |
| Avg | 82.4M | 105.4M | |
| Low | 80.0M | 93.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.7% | 61.9% | |
| Avg | 15.0% | 28.0% | |
| Low | 11.7% | 13.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.67 | 0.13 | |
| Avg | -1.11 | -0.82 | |
| Low | -1.36 | -1.66 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.